CVA Family Office’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
CVA Family Office's EXAS Position: Q1 2026 in Review
CVA Family Office sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12 shares — an estimated $1.22K sold.
CVA Family Office first reported a position in EXAS in Q4 2021 and held it in 8 quarters. The position peaked at $1.22K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- CVA Family Office reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- CVA Family Office sold 12 Exact Sciences shares in Q1 2026, an estimated $1.22K.
- CVA Family Office first reported a position in Exact Sciences in Q4 2021 and held it in 8 quarters.
- CVA Family Office's Exact Sciences position peaked at $1.22K in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.